Skip to main content
Borosil Scientific Limited logo

Borosil Scientific Limited — Investor Relations & Filings

Ticker · BOROSCI ISIN · INE02L001032 LEI · 9845000KHFF9A4F3BF28 BSE.NS Manufacturing
Open in API
Filings indexed 124 across all filing types
Latest filing 2026-05-05 Regulatory Filings
Country IN India
Listing BSE.NS BOROSCI

About Borosil Scientific Limited

https://www.borosilscientific.com

Borosil Scientific Limited specializes in the manufacture and distribution of high-quality laboratory glassware and scientific instruments. The company provides a comprehensive range of products, including beakers, flasks, cylinders, pipettes, and specialized laboratory apparatus designed for precision and durability. Its offerings cater to diverse sectors such as pharmaceuticals, biotechnology, research and development, and educational institutions. Utilizing advanced borosilicate glass technology, the company ensures its products exhibit superior thermal shock resistance and chemical durability. In addition to glassware, the portfolio includes laboratory equipment and primary packaging solutions for the healthcare industry. Borosil Scientific Limited is recognized for its commitment to accuracy and international quality standards, supporting critical scientific processes and industrial applications.

Recent filings

Filing Released Lang Actions
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 95% confidence The document is a declaration under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, confirming that the promoters and persons acting in concert have not made any encumbrance on equity shares during the financial year ended March 31, 2026. It is a regulatory compliance statement related to shareholding and encumbrance status, not a financial report or announcement of financial results. The document length is short (1950 characters) and it is a formal declaration to stock exchanges and audit committee. This fits the category of Regulatory Filings (RNS) as it is a compliance-related announcement that does not fit other specific categories like Major Shareholding Notification or Director's Dealing, since it confirms no change or encumbrance.
2026-05-05 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, confirming that all securities are in dematerialized form and no Demat/Remat requests were received during the quarter ended March 31, 2026. It is a compliance certificate issued by the Registrar and Transfer Agent to the company and submitted to stock exchanges. The document is short (2545 characters) and primarily serves as a regulatory compliance confirmation rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. It is not an announcement of a report but a certification under a regulatory requirement. According to the rules, such officer certifications or confirmations fall under Regulatory Filings (RNS).
2026-04-03 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the closure of the trading window for insiders ahead of the announcement of audited financial results for the quarter and financial year ending March 31, 2026. It references compliance with insider trading regulations and states the trading window closure period but does not contain any financial data, results, or detailed report content. The document is short (1530 characters) and serves as a regulatory announcement related to trading restrictions rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which covers compliance documents and miscellaneous regulatory announcements that do not fit other categories.
2026-03-27 English
General Updates
Investor Presentation Classification · 95% confidence The document is dated February 13, 2026, and is addressed to stock exchanges (BSE and NSE) with a subject line indicating it is an investor presentation on the unaudited financial results for the quarter and nine months ended December 31, 2025. The text includes detailed company information, business segments, market position, and strategic outlook, typical of an investor presentation. It explicitly states it is an "Investor Presentation" and contains forward-looking statements and business overview rather than full financial statements or detailed management discussion. The document length is about 15,000 characters, which is consistent with a detailed presentation but not a full financial report. There is no indication that this is a full annual or quarterly report, audit report, or earnings release. Therefore, the document best fits the category of an Investor Presentation (IP).
2026-02-13 English
Options to purchase securities
Share Issue/Capital Change Classification · 100% confidence The document is an intimation letter from Borosil Scientific Limited to stock exchanges regarding the grant of employee stock options under the company's Employee Stock Option Scheme. It details the number of options granted, pricing, vesting schedule, and other terms. The document is a formal announcement of a capital-related event (grant of stock options) and complies with SEBI regulations. It is not a full financial report, audit, or earnings release, nor is it a management or governance report. It is specifically about a capital change event related to employee stock options, which falls under the category of Share Issue/Capital Change announcements.
2026-02-11 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is an intimation under SEBI Listing Regulation 30 announcing Board approval of the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. It includes the limited review auditor’s report and detailed interim financial statements. This constitutes a comprehensive interim/quarterly report rather than a simple earnings highlight or a standalone audit opinion. Therefore, it is classified as an Interim / Quarterly Report. 9M 2025
2026-02-11 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.